Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.

[This corrects the article DOI: 10.1371/journal.pone.0144359.].

Bibliographic Details
Main Authors: Hélène Bonsang-Kitzis, Léonor Chaltier, Lisa Belin, Alexia Savignoni, Roman Rouzier, Anne-Sophie Hamy, Marie-Paule Sablin, Florence Lerebours, François-Clément Bidard, Paul Cottu, Xavier Sastre-Garau, Marick Laé, Jean-Yves Pierga, Fabien Reyal
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4936688?pdf=render
_version_ 1811221630525898752
author Hélène Bonsang-Kitzis
Léonor Chaltier
Lisa Belin
Alexia Savignoni
Roman Rouzier
Anne-Sophie Hamy
Marie-Paule Sablin
Florence Lerebours
François-Clément Bidard
Paul Cottu
Xavier Sastre-Garau
Marick Laé
Jean-Yves Pierga
Fabien Reyal
author_facet Hélène Bonsang-Kitzis
Léonor Chaltier
Lisa Belin
Alexia Savignoni
Roman Rouzier
Anne-Sophie Hamy
Marie-Paule Sablin
Florence Lerebours
François-Clément Bidard
Paul Cottu
Xavier Sastre-Garau
Marick Laé
Jean-Yves Pierga
Fabien Reyal
author_sort Hélène Bonsang-Kitzis
collection DOAJ
description [This corrects the article DOI: 10.1371/journal.pone.0144359.].
first_indexed 2024-04-12T08:03:59Z
format Article
id doaj.art-f696ea100bd1488e82d016e80881c3c3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T08:03:59Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f696ea100bd1488e82d016e80881c3c32022-12-22T03:41:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01117e015912310.1371/journal.pone.0159123Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.Hélène Bonsang-KitzisLéonor ChaltierLisa BelinAlexia SavignoniRoman RouzierAnne-Sophie HamyMarie-Paule SablinFlorence LereboursFrançois-Clément BidardPaul CottuXavier Sastre-GarauMarick LaéJean-Yves PiergaFabien Reyal[This corrects the article DOI: 10.1371/journal.pone.0144359.].http://europepmc.org/articles/PMC4936688?pdf=render
spellingShingle Hélène Bonsang-Kitzis
Léonor Chaltier
Lisa Belin
Alexia Savignoni
Roman Rouzier
Anne-Sophie Hamy
Marie-Paule Sablin
Florence Lerebours
François-Clément Bidard
Paul Cottu
Xavier Sastre-Garau
Marick Laé
Jean-Yves Pierga
Fabien Reyal
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
PLoS ONE
title Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
title_full Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
title_fullStr Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
title_full_unstemmed Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
title_short Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
title_sort correction beyond axillary lymph node metastasis bmi and menopausal status are prognostic determinants for triple negative breast cancer treated by neoadjuvant chemotherapy
url http://europepmc.org/articles/PMC4936688?pdf=render
work_keys_str_mv AT helenebonsangkitzis correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT leonorchaltier correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT lisabelin correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT alexiasavignoni correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT romanrouzier correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT annesophiehamy correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT mariepaulesablin correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT florencelerebours correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT francoisclementbidard correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT paulcottu correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT xaviersastregarau correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT maricklae correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT jeanyvespierga correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy
AT fabienreyal correctionbeyondaxillarylymphnodemetastasisbmiandmenopausalstatusareprognosticdeterminantsfortriplenegativebreastcancertreatedbyneoadjuvantchemotherapy